Pfizer Korea and Jaeil Pharmaceutical has made the joint promotion agreement for ‘Celebrex’

Published: 2015-01-14 10:39:54

Updated: 2015-01-14 10:39:54

Pfizer Korea (CEO Dong-soo Lee) and Jaeil Pharmaceutical (CEO Suk-jae Sung) held the joint promotion agreement ceremony andstrategy workshop for‘Celebrex (generic name: celecoxib)’ on the last 9^th.

Under the joint promotion agreement, Pfizer Korea and Jaeil Pharmaceutical decided will focus on promotion of Celebrex to mid and large-sized general hospitals and clinics.

Vice president Sun-ah Ki...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.

Pfizer Korea and Jaeil Pharmaceutical has made the joint promotion agreement for ‘Celebrex’

Pfizer Korea (CEO Dong-soo Lee) and Jaeil Pharmaceutical (CEO Suk-jae Sung) held the joint promotion agreement ceremony andstrategy workshop for‘Celebrex (generic name: celecoxib)’ on the last 9th.

Fees

Pfizer Korea (CEO Dong-soo Lee) and Jaeil Pharmaceutical (CEO Suk-jae Sung) held the joint promotion agreement ceremony andstrategy workshop for‘Celebrex (generic name: celecoxib)’ on the last 9^th.